HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Questioning the Epidemiology of Asymptomatic TB

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Tuberculosis (TB) remains one of the world's leading causes of morbidity and mortality. Current TB control strategies focus largely on the binary paradigm of TB, which tackle Mtb infection and the symptomatic stages of the disease as the major drivers of the TB epidemic. However, prevalence surveys have shown that about 50% of cases in which Mycobacterium tuberculosis is isolated from sputum but do not report having symptoms. Therefore, asymptomatic TB may play an important role in TB transmission. However, no field study has demonstrated direct transmission from a subclinical TB case to a confirmed secondary case. TB-QUEST is an ERC-funded epidemiological field study that aims to provide direct evidence of effective transmission from asymptomatic TB cases to their close contacts using advanced genomic methods, and to better characterize the asymptomatic stage of TB within the natural history of disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• 18 years of age or older

• Documented HIV infection

• Presenting at a health facility for routine HIV care

• On ART for less than 6 months

• No evidence of viral suppression

• Documented CD4 count \>350 copies/ul

• TB-suggestive x-ray

• Verified absence of fever and cough, as ascertained through the symptom trackers

⁃ Contacts:

Locations
Other Locations
Mozambique
Centro de Investigação em Saúde de Manhiça (CISM)
RECRUITING
Manhiça
Contact Information
Primary
Alberto L. Garcia-Basteiro, MD
alberto.garcia-basteiro@isglobal.org
+34 93 227 1806
Backup
Joanna Ehrlich
joanna.ehrlich@isglobal.org
+34 93 227 1806
Time Frame
Start Date: 2025-08-11
Estimated Completion Date: 2029-05
Participants
Target number of participants: 6770
Treatments
Asymptomatic
Contacts of bacteriologically-confirmed asymptomatic TB index cases
Symptomatic
Contacts of bacteriologically-confirmed symptomatic TB index cases
Related Therapeutic Areas
Sponsors
Leads: Barcelona Institute for Global Health

This content was sourced from clinicaltrials.gov